Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial.
Nawaf YassiHenry ZhaoLeonid ChurilovBruce C V CampbellTeddy Y WuHenry MaAndrew K CheungTimothy John KleinigHelen BrownPhilip M C ChoiJiann-Shing JengAnnemarei RantaHao-Kuang WangGeoffrey C CloudRohan S GrimleyDarshan G ShahNeil James SprattDer-Yang ChoKarim MahawishLauren M SandersJohn WorthingtonBenjamin ClissoldAtte MeretojaVignan YogendrakumarMai Duy TonPhuc Duc DangNguyen Thai My PhuongHuy-Thang NguyenChung-Y HsuGagan SharmaPeter J MitchellBernard YanMark W ParsonsChristopher R LeviGeoffrey Alan DonnanStephen M DavisPublished in: Stroke and vascular neurology (2021)
We describe the rationale and protocol of STOP-MSU, a phase II trial of tranexamic acid in patients with ICH within 2 hours from onset, based in participating mobile stroke units and emergency departments.